DelveInsight's "CABLIVI Market Size, Forecast, and Market Insight Report" highlights the details around CABLIVI, a von ...

Developed by Sanofi, CABLIVI is the first FDA-approved nanobody therapy for this condition. Increasing awareness, improved diagnostic rates, and rising demand for targeted therapies in hematology ...

Sarah Blackburn's experience highlights the importance of routine medical checkups. Despite a healthy lifestyle, a full-body ...

The patient tolerated the procedure well without complication. Follow-up CTA demonstrated successful embolization of the splenic artery aneurysm. Rapidly increasing size, presence in a premenopausal ...